4 clinical trials found.
-
A Multicenter Randomized Double-blind Placebo- controlled Parallel-group Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus
SLE is a chronic autoimmune disease in which the immune system attacks the body’s cells and tissue, and can affect almost any organ system. The ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
A Phase 2 Randomized Double-blind Placebo-controlled Evaluation of the Safety and Efficacy of BMS-986165 with Background Treatment in Subjects with Lupus Nephritis
The purpose of this research study is to see if a test medicine named BMS-986165 will help treat kidney inflammation caused by lupus nephritis. It ...
Phase
Interventional
TRIAL ROLE: Principal Investigator
-
The Dynamic Contrast Enhanced MRI study of lupus nephritis
The main purpose of this research study is to find out whether magnetic resonance imaging (MRI) can detect abnormalities in kidneys in lupus nephritis and ...
Phase N/A
Observational
TRIAL ROLE: Principal Investigator
-
LEUKOTRIENE AFFECT ON LUPUS ATHEROSCLEROSIS (THE LALA STUDY) A pilot proof of concept observational single-center study of the levels of leukotriene B4 in patients with systemic lupus erythematosus and non-lupus subjects with and without cardiovascula
The purpose of this study is to obtain blood in order to identify the level of leukotriene B4 (LTB4) and myeloperoxidase (MPO) in patients with ...
Phase N/A Observational
TRIAL ROLE: Principal Investigator
